399 related articles for article (PubMed ID: 33389490)
1. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
Wen L; Yang H; Ma L; Fu P
Mol Cell Biochem; 2021 Mar; 476(3):1377-1386. PubMed ID: 33389490
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
3. Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Hu Y; Shi Y; Chen H; Tao M; Zhou X; Li J; Ma X; Wang Y; Liu N
Front Immunol; 2022; 13():858494. PubMed ID: 35309342
[TBL] [Abstract][Full Text] [Related]
4. Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation.
Shui G; Cai Z; Wang F; Chen T; Huang X; Cai Y; Mi X
BMC Complement Med Ther; 2022 Oct; 22(1):278. PubMed ID: 36271349
[TBL] [Abstract][Full Text] [Related]
5. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption.
Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J
Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
7. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
[TBL] [Abstract][Full Text] [Related]
8. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
Qiu YY; Tang LQ
Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
[TBL] [Abstract][Full Text] [Related]
9. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.
Wang C; Pan Y; Zhang QY; Wang FM; Kong LD
PLoS One; 2012; 7(6):e38285. PubMed ID: 22701621
[TBL] [Abstract][Full Text] [Related]
10. Artificially Cultivated
Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
[TBL] [Abstract][Full Text] [Related]
11. The role of uric acid in inflammasome-mediated kidney injury.
Braga TT; Foresto-Neto O; Camara NOS
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):423-431. PubMed ID: 32452918
[TBL] [Abstract][Full Text] [Related]
12. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
14. Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome.
Yin L; Zhao H; Zhang H; Li Y; Dong Y; Ju H; Kong F; Zhao S
Front Immunol; 2021; 12():652446. PubMed ID: 34093539
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury.
Kim SM; Kim YG; Kim DJ; Park SH; Jeong KH; Lee YH; Lim SJ; Lee SH; Moon JY
Front Immunol; 2018; 9():2563. PubMed ID: 30483252
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet.
Cui J; Hong P; Li Z; Lin J; Wu X; Nie K; Zhang X; Wan J
Int Immunopharmacol; 2023 Jul; 120():110353. PubMed ID: 37276828
[TBL] [Abstract][Full Text] [Related]
18. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
19. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
Li L; Qian K; Sun Y; Zhao Y; Zhou Y; Xue Y; Hong X
Bioengineered; 2021 Dec; 12(1):4805-4815. PubMed ID: 34338149
[TBL] [Abstract][Full Text] [Related]
20. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
